FDA approves drug for multiple sclerosis - CNN.com
Links shared publicly online about this topic.
- 1,436total visits
FDA approves drug for multiple sclerosis - CNN.com
View full resource at rss.cnn.com
Tags: Multiple Sclerosis, Drug, FDA
Most Recently Shared on January 23, 2010 at 2:26 am By:
FDA OKs drug for multiple sclerosis http://bit.ly/4t2ktl
MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA
medicalnewstoday.com — “Novartis says it has updated prescribing data for multiple sclerosis therapy Gilenya (Fingolimod) after a review by the Food and Drug Administration (FDA). The prescribing information inclu” View full resource at medicalnewstoday.com
Most Recently Shared on April 20, 2012 at 4:05 pm By:
MNT Drug Approvals Health News
MS Therapy Gilenya (Fingolimod) Updated Prescribing Data In USA http://t.co/wfddGJkc #regulatory
Symposier - Andrew Goodman, M.D. discusses new drug for Multiple Sclerosis | Joeygiggles Health Topics | Scoop.it
scoop.it — “Uploaded and Shared in Youtube by: URMCPR — A new treatment for multiple sclerosis (MS) that improves mobility for some patients earned FDA approval in January 2010.” View full resource at scoop.it
Most Recently Shared on March 18, 2012 at 5:27 pm By:
Symposier - Andrew Goodman, M.D. discusses new drug for Multiple Sclerosis | @scoopit via @SympoNeurology http://t.co/qFOFdE28 pls Rt #JGF
Arthritis drugs hold promise for multiple sclerosis
sciencedaily.com — “Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.” View full resource at sciencedaily.com
Most Recently Shared on March 18, 2012 at 1:14 pm By:
Arthritis drugs hold promise for multiple sclerosis http://t.co/pmK7KFlx
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients | Mail Online
dailymail.co.uk — “The NHS rationing body has approved the drug fingolimod which can halve relapses among sufferers compared with standard treatments.” View full resource at dailymail.co.uk
Most Recently Shared on March 17, 2012 at 12:56 pm By:
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients: The NHS rationing bo... http://t.co/deH3thL6
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients - QualityPoint Technologies
qualitypointtech.net — “The NHS rationing body has approved the drug fingolimod which can halve relapses among sufferers compared with standard treatments. (Source: the Mail online | Health)” View full resource at qualitypointtech.net
Most Recently Shared on March 17, 2012 at 12:00 pm By:
Multiple Sclerosis: World-first pill for MS to be offered to thousands of British patients: The NHS rationing body... http://t.co/iHvUwA2D
Arthritis Drugs Hold Promise for Multiple Sclerosis
newswise.com — “Research suggests that a class of drugs for rheumatoid arthritis seeking approval this year could be effective against other autoimmune diseases.” View full resource at newswise.com
Most Recently Shared on March 15, 2012 at 6:31 pm By:
Women In Pain Health Organization
Arthritis Drugs Hold Promise for Multiple Sclerosis http://t.co/fn9e83cb http://t.co/sloAazNf
Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis - MarketWatch
marketwatch.com — “Biogen Idec Submits Application to FDA for Approval of Oral BG-12 to Treat Multiple Sclerosis - MarketWatch” View full resource at marketwatch.com
Most Recently Shared on February 28, 2012 at 1:40 pm By:
John Carroll Health Communicator
Biogen Idec files NDA for MS drug BG-12 http://t.co/UZzyHMjU #biotech
The JC Virus Antibody Test Goes Public - New Treatments - Multiple Sclerosis
healthcentral.com — “Biogen Idec was pleased to announce last week that the FDA has approved an update to the prescription labeling of their monthly IV monoclonal antibody medicatio...” View full resource at healthcentral.com
Most Recently Shared on February 3, 2012 at 9:46 pm By:
The JC Virus Antibody Test Goes Public: Biogen Idec was pleased to announce last week that th... http://t.co/9VKQqoaO via @healthcentral
Patient Died Soon After Taking MS Drug Fingolimod : Internal Medicine News
internalmedicinenews.com — “Internal Medicine News Digital Network is the online destination and multimedia properties of Internal Medicine News, the independent news publication. Our breaking news covers all areas of internal medicine including adolescent medicine; cardiovascular disease; dermatology; diabetes, endocrinology and metabolism; gastroenterology; geriatric medicine; infectious diseases; mental health; oncology and hematology; nephrology and urology; neurology; pulmonary disease and sleep medicine; practice tre” View full resource at internalmedicinenews.com
Most Recently Shared on December 20, 2011 at 9:35 pm By:
Bob Finn - Medical News Net Health News
FDA reports that a patient died soon after the first dose of multiple sclerosis drug fingolimod - http://t.co/0wXIZGAl
Roche - Media: News and Press Releases
roche.com — “Press releases, media archive with backgrounders, photo and video material. Subscribe to our events podcast and regular updates via RSS-feed.” View full resource at roche.com
Most Recently Shared on October 20, 2011 at 3:02 pm By:
Phase II study showed significant reduction in disease activity for multiple sclerosis patients for almost two years http://t.co/UGOrjk5Y
FDA OKs diabetes, cholesterol combo drug - Related Stories - DiabetesPro SmartBrief
smartbrief.com — “Merck & Co. secured marketing approval from the FDA for Juvisync, a treatment containing the firm's type 2 diabetes pill Januvia and cholesterol-lowering statin simvastatin. The combination was approved for marketing in multiple strengths. "Dose selection should factor in what other drugs the patie…” View full resource at smartbrief.com
Most Recently Shared on October 10, 2011 at 4:03 pm By:
Jill Weisenberger Nutritionist and Dietitian
Available in 6 dosages RT @Eatingsoulfully: FDA OKs diabetes, cholesterol combo drug http://t.co/5Wp37M2a #diabetes
Diaphragm pacing system receives FDA approval for use with ALS patients
medicalxpress.com — “An electronic system that stimulates the nerve of the diaphragm muscles has received approval from the Food and Drug Administration (FDA) for use in patients with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease. The system called NeuRx Diaphragm Pacing System (DPS) will help ...” View full resource at medicalxpress.com
Most Recently Shared on September 29, 2011 at 8:45 pm By:
PhysOrg Health News Health News
Diaphragm pacing system receives FDA approval for use with ALS patients http://t.co/uLfR6h75
FDA approves onabotulinumtoxinA for certain types of incontinence - - ModernMedicine
modernmedicine.com — “The FDA recently approved onabotulinumtoxinA (Botox) injection for the treatment of urinary incontinence due to detrusor overactivity associated with a neurologic condition (eg, spinal cord injury, multiple sclerosis) in adults who have an inadequate response to or are intolerant of an anticholinergic medication.” View full resource at modernmedicine.com
Most Recently Shared on September 7, 2011 at 8:01 pm By:
FDA approves onabotulinumtoxinA for incontinence in adults with neurologic conditions: The FDA recently approved... http://t.co/GQmreLx
Regeneron Call Options Climb As Shares Soar On Roche's Setback - Forbes
forbes.com — “Shares in the biotechnology company Regeneron, which is seeking FDA approval of its Eylea ophthalmic solution to slow the progression of wet age-related macular degeneration and improve vision in those patients, surged 15.4% to an intraday high of $68.60 today. An FDA panel already voted unanimously to recommend approval of Eylea back in June. Investors expecting shares in REGN to continue to climb picked up calls across multiple expiries.” View full resource at forbes.com
Most Recently Shared on September 2, 2011 at 11:25 pm By:
Drugs and Devices OW OW Health
Regeneron Call Options Climb As Shares Soar On Roche's Setback: Shares in the biotechnology company Reg... http://t.co/gaadMj1 #drug
FDA Approves Botox to Treat Urinary Incontinence in People with Neurological Conditions Including Multiple Sclerosis and Spinal Cord Injury -- American Academy of Neurology
aan.com — “The U.S. Food and Drug Administration approves Botox (onabotulinumtoxinA) injection to treat urinary incontinence in people with neurologic conditions such as spinal cord injury and multiple sclerosis who have overactivity of the bladder. Read the FDA news release.” View full resource at aan.com
Most Recently Shared on August 28, 2011 at 12:14 pm By:
FDA Approves Botox to Treat Urinary Incontinence in People with Neurological Conditions Including Multiple Scler... http://t.co/hODwJW9
Advertisement
